Research of Type 1 Diabetes

Can an Old Drug Delay Type 1 Diabetes?

Researchers have long known that diabetes runs in families, but it’s only been about 20 years since they have successfully isolated gene and antibody combinations that serve as reliable genetic predictors of the risk of developing Type 1 diabetes.

A great many people who have Type 1 also have inherited genetic codes for antigens known as DR4 and DQ8; an antigen is any substance that may cause your body to produce antibodies against it. Post-diagnostic genetic testing of patients who have developed Type 1 diabetes has shown that about 90% have one or both of these genetic codes, and 60% have the DQ8 gene alone. The DQ8 gene also has been linked, although less conclusively, to a very small population of people with Type 2 diabetes.

The DQ8 gene is heavily distributed among people in Central America and northern South America. It’s also found in high frequency among Americans who live near the Gulf of Mexico and in the Mississippi Valley whose lineages go back to Caribbean and indigenous North American peoples. It’s found frequently in northern Europe, Scandinavia, and Japan, as well.

The Barbara Davis Center for Childhood Diabetes, located at the University of Colorado Medical School, is backing research into a link between DQ8 and Type 1 diabetes. Researchers are trying to see if they can block DQ8 to delay or block the progression of Type 1 diabetes.

To do this, they are undertaking a clinical trial of methyldopa, an oral drug which has been long used to alleviate hypertension. Methyldopa, once commonly branded as Aldomet, was developed in the 1960’s as an anti-anxiety and anti-tremor remedy for patients with neurological disorders. It was later shown to work by dilating blood vessels. As a psychoactive drug, it’s fallen out of favor since being replaced by other formulations for long-term use but it’s still prescribed for relief of short-term high blood pressure (think gestational diabetes).

Dr. Aaron Michels, who is chief investigator for the University of Colorado methyldopa clinical study, is co-author of a paper published in the April 2015 edition of World Journal of Diabetes that describes the potential of using methyldopa to treat newly diagnosed Type 1 patients. The hope is that this approach might slow progression of beta cell loss, and possibly delay or prevent onset of cell loss in patients exhibiting signs of prediabetes.

Methyldopa appears to work as a blocker; it neither interacts with the insulin molecule nor the pancreatic beta cell. Rather, it scrambles the signal from the antibody-summoning HLA DQ8 molecule, which might confer protection to islet cells. Further, researchers see no reason to expect that administering methyldopa will interfere with T-cell functions.

Methyldopa emerged as a candidate for inhibiting the fatal attraction between T cells and pancreatic islet beta cells through complicated chemical analyses aided by Dr. Mark Atkinson and Dr. David Ostrov, researchers at the University of Florida. Dr. Ostrov, a structural biologist, employed a supercomputer to perform what were essentially docking simulations of the DQ8 molecule’s receptor with structures of 140,000 existing small molecule medications – a process involving some 560 million permutations. Methyldopa was one of the finalist medicines that docked well with DQ8. Subsequent in vitro (“test tube”) and in vivo (living organism) tests with mice confirmed the likelihood that the drug would be effective.

Dr. Michels then enrolled 20 volunteer patients for a first phase clinical trial. 17 patients have thus far volunteered to receive methyldopa in three dosages at or below the therapeutic dose for high blood pressure. In the coming months, the study volunteers will continue to return for A1C monitoring and blood glucose testing.

Dr. Michels hopes to have this trial phase completed by early 2016, after which he would like to conduct a next-phase clinical trial with a larger group of recently diagnosed children and adults. The results of this broader, placebo-controlled study could lay the foundation for developing a methyldopa “vaccine” to delay onset or progression of beta cell destruction. The possibility of a remission or delay of even four to six years for a young child amounts to a breakthrough, as every year of maturity allows a child’s body to grow without complications of diabetes, and the child to develop skills to cope with the rigors of diabetes self-care.

If you want to contribute to a fundraising effort to support this type of research, you can go to

Thanks for reading this Insulin Nation article. Want more Type 1 news? Subscribe here.

Have Type 2 diabetes or know someone who does? Try Type 2 Nation, our sister publication.

Jim Cahill is a former staff writer for Insulin Nation and a former editor of Type 2 nation.

Related Articles


  1. “Terrific post however , I was wanting to know if you could write a litte more on this topic? I’d be very thankful if you could elaborate a little bit more. Cheers!”

  2. otnpeblkzc,Very informative useful, infect very precise and to the point. Im a student a Business Education and surfing things on Google and found your website and found it very informative.

  3. jmbkxinb,If you want a hassle free movies downloading then you must need an app like showbox which may provide best ever user friendly interface.

  4. “Have you ever thought about writing an ebook or guest authoring on other blogs? I have a blog based on the same ideas you discuss and would really like to have you share some stories/information. I know my viewers would value your work. If you’re even remotely interested, feel free to send me an e-mail.”

  5. It’s amazing to pay a visit this web site and reading the views of
    all friends about this piece of writing, while I am also zealous
    of getting knowledge.

  6. atkbhe,Very informative useful, infect very precise and to the point. Im a student a Business Education and surfing things on Google and found your website and found it very informative.

  7. Hmm is anyone else encountering problems with the
    images on this blog loading? I’m trying to figure out if its a problem
    on my end or if it’s the blog. Any responses would be greatly appreciated.

  8. I need to to thank you for this very good read!! I certainly loved every little bit of it.

    I have got you saved as a favorite to check out new things
    you post…

  9. I do not even know how I ended up here, but I thought this
    post was great. I do not know who you are but
    definitely you’re going to a famous blogger if you are
    not already 😉 Cheers!

  10. Hey there, You have done an incredible job. I’ll definitely digg it and personally suggest
    to my friends. I am sure they’ll be benefited from this web site.

  11. eoliofYeezy Boost 350,Definitely believe that which you said. Your favourite justification appeared to be on the net the simplest thing to remember of.

  12. dpqzptzjoi,If you want a hassle free movies downloading then you must need an app like showbox which may provide best ever user friendly interface.

  13. pfhiamglu,If you are going for best contents like I do, just go to see this web page daily because it offers quality contents, thanks!

  14. Game Killer Apk Download Latest Version for Android (No Ad) … Guess not because Game killer full version app is not available on Play store.

  15. “There are signs that it has been 10 years. The stock market bull market is about to peak, because (now) US stocks are definitely not cheap and very sensitive to any bad news.” The number of weekly claims for unemployment benefits in the United States has fallen to its lowest level since 1969,

  16. “Have you ever thought about creating an ebook or guest authoring on other websites? I have a blog centered on the same information you discuss and would really like to have you share some stories/information. I know my readers would appreciate your work. If you are even remotely interested, feel free to send me an e mail.”

  17. The European Commission said on Friday that Volkswagen, BMW and Daimler violated antitrust laws and jointly delayed the launch of two emission purification systems between 2006 and 2014. Margrethe Vestager, the EU’s top official in charge of competition, said in a statement that companies can work together to improve products, but can’t agree not to compete for quality.

  18. In his first interview since launching his campaign on Thursday, former Vice President Joe Biden struggled with apologies inside the friendly confines of The View. The hosts pressed him to apologize to the seven women who had accused him of inappropriate behavior, which he eventually did, adding the qualifier that he was not sorry in the sense that I think I did anything that was intentionally designed to do anything wrong or be inappropriate.

  19. “I’m so happy to read this. This is the kind of info that needs to be given and not the random misinformation that’s at the other blogs. Appreciate your sharing this greatest doc.”

  20. He couldnt drive himself into work on Wednesday, however, and said he still has some restrictions as he goes back to work and begins to rehab his hip.

  21. I’m impressed, I must say. Rarely do I encounter a blog that’s equally educative and engaging, and
    without a doubt, you have hit the nail on the head.
    The problem is something which too few people are speaking intelligently about.
    I am very happy that I found this during my hunt
    for something concerning this.

  22. “I needed to create you the tiny remark to finally say thank you over again with your striking ideas you’ve featured above. It is really wonderfully generous with people like you to grant unreservedly precisely what most of us would have supplied as an electronic book to earn some profit on their own, most importantly considering that you might well have done it in case you desired. The principles as well worked like a fantastic way to realize that most people have the identical keenness really like mine to see good deal more on the subject of this matter. I’m certain there are millions of more fun opportunities ahead for many who see your blog post.”

  23. Simply want to say your article is as astonishing.
    The clearness in your post is simply cool and i could assume you are an expert on this subject.
    Fine with your permission allow me to grab your feed to keep up to
    date with forthcoming post. Thanks a million and please continue the gratifying

  24. “Thank you for the sensible critique. Me and my neighbor were just preparing to do some research about this. We got a grab a book from our area library but I think I learned more from this post. I am very glad to see such fantastic info being shared freely out there.”

Leave a Reply

Your email address will not be published.

Back to top button